Xtant Medical Valuation
| XTNT Stock | USD 0.40 0.01 2.44% |
Xtant Medical is undervalued. Xtant Medical Holdings maintains a prevalent Real Value of $0.63 per share. The last-minute price of the company is $0.4. Our model calculates the value of Xtant Medical Holdings from examining the company fundamentals such as Profit Margin of (0.03) %, return on asset of -0.11, and Current Valuation of 84.96 M as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Xtant Medical's valuation include:
Price Book 1.216 | Enterprise Value 85 M | Enterprise Value Ebitda 46.0087 | Price Sales 0.5012 | Enterprise Value Revenue 0.7461 |
Undervalued
Today
Please note that Xtant Medical's price fluctuation is abnormally volatile at this time. Calculation of the real value of Xtant Medical Holdings is based on 3 months time horizon. Increasing Xtant Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Xtant Medical's intrinsic value may or may not be the same as its current market price of 0.40, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.4 | Real 0.63 | Target 1.35 | Hype 0.41 | Naive 0.35 |
The intrinsic value of Xtant Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Xtant Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Xtant Medical Holdings helps investors to forecast how Xtant stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Xtant Medical more accurately as focusing exclusively on Xtant Medical's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Xtant Medical's intrinsic value based on its ongoing forecasts of Xtant Medical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Xtant Medical's closest peers.
Xtant Medical Cash |
|
Xtant Valuation Trend
Xtant Medical's real value is important for investors to make better decisions and a more accurate overall view of Xtant Medical's financial worth over time. Using both Xtant Medical's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Xtant Medical Total Value Analysis
Xtant Medical Holdings is at this time estimated to have valuation of 84.96 M with market capitalization of 55.6 M, debt of 23.56 M, and cash on hands of 16.5 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Xtant Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
84.96 M | 55.6 M | 23.56 M | 16.5 M |
Xtant Medical Investor Information
About 65.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 1.22. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Xtant Medical Holdings recorded a loss per share of 0.13. The entity last dividend was issued on the 14th of February 2018. The firm had 1:12 split on the 14th of February 2018. Based on the analysis of Xtant Medical's profitability, liquidity, and operating efficiency, Xtant Medical Holdings may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.Xtant Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Xtant Medical has an asset utilization ratio of 98.59 percent. This implies that the Company is making $0.99 for each dollar of assets. An increasing asset utilization means that Xtant Medical Holdings is more efficient with each dollar of assets it utilizes for everyday operations.Xtant Medical Ownership Allocation
Xtant Medical Holdings retains a total of 139.01 Million outstanding shares. Over half of Xtant Medical's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.Xtant Medical Profitability Analysis
The company reported the previous year's revenue of 91.3 M. Net Income was 660 K with profit before overhead, payroll, taxes, and interest of 32.14 M.About Xtant Medical Valuation
The stock valuation mechanism determines Xtant Medical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Xtant Medical Holdings based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Xtant Medical. We calculate exposure to Xtant Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Xtant Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 55.5 M | 34 M | |
| Pretax Profit Margin | (0.01) | (0.01) | |
| Operating Profit Margin | (0.11) | (0.12) | |
| Net Profit Margin | 0.01 | 0.01 | |
| Gross Profit Margin | 0.61 | 0.49 |
Xtant Medical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Xtant Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 126.8 M |
Xtant Medical Current Valuation Indicators
Xtant Medical's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Xtant Medical's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Xtant Medical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Xtant Medical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Xtant Medical's worth.Additional Tools for Xtant Stock Analysis
When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.